DB2115 tertahydrochloride
Modify Date: 2024-01-18 18:29:46
DB2115 tertahydrochloride structure
|
Common Name | DB2115 tertahydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1366126-19-3 | Molecular Weight | 704.48 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H34Cl4N8O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DB2115 tertahydrochlorideDB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1]. |
| Name | DB2115 tertahydrochloride |
|---|
| Description | DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1]. |
|---|---|
| Related Catalog | |
| Target |
PU.1[1] |
| References |
[1]. W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1. |
| Molecular Formula | C32H34Cl4N8O2 |
|---|---|
| Molecular Weight | 704.48 |